| A 24-week, all-oral regimen for rifampin-resistant tuberculosis BT Nyang’wa, C Berry, E Kazounis, I Motta, N Parpieva, Z Tigay, ... New England Journal of Medicine 387 (25), 2331-2343, 2022 | 117 | 2022 |
| Factors associated with unfavorable treatment outcomes in new and previously treated TB patients in Uzbekistan: a five year countrywide study J Gadoev, D Asadov, M Tillashaykhov, K Tayler-Smith, P Isaakidis, ... PloS one 10 (6), e0128907, 2015 | 76 | 2015 |
| Standardised shorter regimens versus individualised longer regimens for rifampin-or multidrug-resistant tuberculosis S Abidi, J Achar, MMA Neino, D Bang, A Benedetti, S Brode, JR Campbell, ... European Respiratory Journal 55 (3), 2020 | 70 | 2020 |
| Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan S Horter, B Stringer, J Greig, A Amangeldiev, MN Tillashaikhov, ... BMC Infectious Diseases 16, 1-15, 2016 | 39 | 2016 |
| Recurrent tuberculosis and associated factors: A five-year countrywide study in Uzbekistan J Gadoev, D Asadov, AD Harries, N Parpieva, K Tayler-Smith, P Isaakidis, ... PLoS One 12 (5), e0176473, 2017 | 33 | 2017 |
| Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study M Bastard, E Sanchez-Padilla, P Du Cros, AK Khamraev, N Parpieva, ... PloS one 13 (3), e0193491, 2018 | 31 | 2018 |
| Особенности диагностики и лечении при генерализированных формах туберкулёза НН Парпиева, ИХ Усмонов, НЮ Кобилов, МФ Жумаев Новый день в медицине. Бухара,(2), 424-428, 2020 | 26 | 2020 |
| Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan JM Trauer, J Achar, N Parpieva, A Khamraev, JT Denholm, D Falzon, ... BMC medicine 14, 1-11, 2016 | 24 | 2016 |
| Person-centred care in practice: Perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan S Horter, B Stringer, N Gray, N Parpieva, K Safaev, Z Tigay, J Singh, ... BMC Infectious Diseases 20, 1-11, 2020 | 23 | 2020 |
| Population structure of drug-resistant Mycobacterium tuberculosis in Central Asia A Engström, U Antonenka, A Kadyrov, G Kalmambetova, K Kranzer, ... BMC infectious Diseases 19, 1-5, 2019 | 19 | 2019 |
| Характеристика лекарственной устойчивости микобактерий туберкулеза у ВИЧ-инфицированных НН Парпиева, ВГ Белоцерковец, МН Тилляшайхов, ЛТ Тураев Туберкулез и болезни легких 88 (5), 101-102, 2011 | 18 | 2011 |
| Trends, characteristics and treatment outcomes of patients with drug-resistant tuberculosis in Uzbekistan: 2013–2018 K Safaev, N Parpieva, I Liverko, S Yuldashev, K Dumchev, J Gadoev, ... International Journal of Environmental Research and Public Health 18 (9), 4663, 2021 | 17 | 2021 |
| Treatment outcomes and adverse reactions in patients with multidrug-resistant tuberculosis managed by ambulatory or hospitalized care from 2010-2011 in Tashkent, Uzbekistan L Kalandarova, M Tillashaikhov, N Parpieva, S Saidova, J Gadoev, ... Public health panorama 2 (01), 21-29, 2016 | 17 | 2016 |
| Лечение больных с сочетанной инфекцией ВИЧ/туберкулез МН Тилляшайхов, ВГ Белоцерковец, НН Парпиева, ТЮ Якуббеков, ... Туберкулез и болезни легких 88 (5), 185-185, 2011 | 17 | 2011 |
| Effectiveness and safety of a shorter treatment regimen in a setting with a high burden of multidrug-resistant tuberculosis A Trubnikov, A Hovhannesyan, K Akopyan, A Ciobanu, D Sadirova, ... International Journal of Environmental Research and Public Health 18 (8), 4121, 2021 | 16 | 2021 |
| Стоматологический статус и совершенствование лечения патологических изменений в полости рта детей, больных туберкулезом ИЗ Утешева, СС Муртазаев, НН Парпиева Вестник науки и образования, 26-31, 2021 | 16 | 2021 |
| ‘They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan B Stringer, K Lowton, M Tillashaikhov, N Parpieva, D Ulmasova, ... The International Journal of Tuberculosis and Lung Disease 20 (8), 1084-1090, 2016 | 14 | 2016 |
| Rapid tuberculosis diagnostics including molecular first-and second-line resistance testing based on a novel microfluidic DNA extraction cartridge M Beutler, AR Homann, M Mihalic, S Plesnik, L Niebling, M Eckart, ... The Journal of Molecular Diagnostics 23 (5), 643-650, 2021 | 13 | 2021 |
| Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan P du Cros, A Khamraev, Z Tigay, T Abdrasuliev, J Greig, G Cooke, ... ERJ Open Research 7 (1), 2021 | 13 | 2021 |
| Capacity of Abbott RealTime MTB RIF/INH to detect rifampicin-and isoniazid-resistant tuberculosis S Hofmann-Thiel, N Molodtsov, C Duffner, A Kadyrov, G Kalmambetova, ... The International Journal of Tuberculosis and Lung Disease 23 (4), 458-464, 2019 | 12 | 2019 |
